Lotte stock: Lotte supports KRW 282.5 billion loans. What it means for Lotte stock

Published on 10/24/2026 at 03:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The commitment covers principal, interest and fees through November 2029. For Lotte stock, Q2 revenue reached KRW 4.09 trillion.

Capital support and results date

Lotte approved KRW 282.5 billion in loan support on October 22, 2026.
Second-quarter revenue reached KRW 4.09 trillion against a KRW 4.12 trillion estimate.
Lotte is scheduled to report its next results on November 18, 2026.

Lotte, KR7004990008, Illustration mit AI erstellt.

Lotte (KR7004990008) approved support for up to KRW 282.5 billion in loans for subsidiary Lotte Biologics on October 22, 2026. According to TipRanks, the commitment covers principal, interest and fees if the subsidiary cannot repay its borrowings and runs through November 2029. For Lotte stock, the decision puts the group balance sheet at the center of its biologics expansion.

Three dated capital moves

Lotte's recent financing actions show a clear sequence. On August 18, 2026, Lotte Biologics received KRW 255.26 billion in funding from Lotte Corporation and Hotel Lotte, according to MarketScreener. On September 29, 2026, Lotte announced hybrid bonds worth KRW 100 billion for debt repayment. On October 22, 2026, the company approved the KRW 282.5 billion loan support commitment for Lotte Biologics.

What does the support mean?

The latest commitment links Lotte's corporate financing capacity to the capital needs of its biologics subsidiary. The planned support period extends from October 2026 to November 2029, while Lotte Biologics is expanding its contract development and manufacturing operations. That structure can help secure funding for facilities, but it also leaves Lotte exposed to repayment shortfalls if the subsidiary's resources prove insufficient.

Revenue trails the estimate

Lotte's second-quarter 2026 revenue reached KRW 4.09 trillion, below the KRW 4.12 trillion estimate, while net income was KRW 27.32 billion after KRW 1.93 billion in the preceding quarter. TradingView lists November 18, 2026 as the next earnings date. The upcoming report will show whether operating performance is keeping pace with the group's financing commitments.

Dates for the balance sheet

The next scheduled reporting date is November 18, 2026. The loan support obligation is expected to continue through November 2029, according to TipRanks.

Business mix shapes the risk

LOTTE Corporation operates across food, retail, chemicals, construction, tourism and finance, with Lotte Biologics adding a capital-intensive growth business. The group reported total assets of KRW 23.65 trillion and total shareholders' equity of KRW 9.27 trillion for the second quarter of 2026. Its market capitalization was KRW 1.7 trillion as of October 23, 2026, while the 52-week range was KRW 21,150.00 to KRW 39,600.00.